MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$82,478K
Cash and cash
equivalents
$15,858K
Prepaid expenses and
other current assets
$6,913K
Restricted cash, current
portion
$37K
Total current assets
$105,286K
Goodwill
$10,502K
Property and equipment,
net
$460K
Restricted cash, net of
current portion
$210K
Total assets
$116,458K
Total liabilities,
mezzanine equity and...
$116,458K
Total stockholders
equity
$83,049K
Total liabilities
$33,409K
Accumulated deficit
-$448,522K
Additional paid-in capital
$531,485K
Derivative liability,
non-current
$18,000K
Total current
liabilities
$12,940K
Royalty obligation
$2,000K
Deferred tax liability,
net
$434K
Other long-term
liabilities
$35K
Accumulated other
comprehensive income
$68K
Common stock0.001 par
value 200,000,000...
$18K
Accrued expenses and
other current...
$12,803K
Accounts payable
$137K
Back
Back
Balance Sheet
source: myfinsight.com
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)